ketanserin has been researched along with alfentanil in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Arroyo, JL; Carrasco, MS; De Castro, J; Esteban, J; Sanchez, G | 1 |
Cline, EJ; Koob, GF; Smith, NT; Weinger, MB | 1 |
Chen, DY; Koob, GF; Lau, C; Lin, T; Smith, NT; Weinger, MB | 1 |
8 other study(ies) available for ketanserin and alfentanil
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
[Endocrine and metabolic changes induced in surgery by the combination of ketanserin and alfentanyl].
Topics: Abdomen; Adolescent; Adult; Aged; Alfentanil; Analgesics, Opioid; Drug Therapy, Combination; Female; Fentanyl; Humans; Intraoperative Complications; Ketanserin; Male; Middle Aged; Piperidines; Premedication; Serotonin Antagonists; Stress, Physiological | 1985 |
Ketanserin pretreatment reverses alfentanil-induced muscle rigidity.
Topics: Adjuvants, Anesthesia; Alfentanil; Animals; Fentanyl; Ketanserin; Male; Muscle Rigidity; Preanesthetic Medication; Rats | 1987 |
A role for CNS alpha-2 adrenergic receptors in opiate-induced muscle rigidity in the rat.
Topics: Adrenergic alpha-Agonists; Alfentanil; Animals; Electromyography; Hindlimb; Imidazoles; Ketanserin; Male; Medetomidine; Muscle Rigidity; Naloxone; Narcotics; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2 | 1995 |